Acnatac 10 mg/g + 0 clinical trials

A multicenter, randomized, double-blind, parallel, three-arm, active- and placebo-controlled therapeutic equivalence study for the comparison of clindamycin + tretinoin/Verisfield gel (1+0.025)% with Acnatac®/Meda gel [clindamycin + tretinoin (1+0.025)%] in the treatment of acne vulgaris.

This study compares a new gel for acne, made by Verisfield, with an existing one called Acnatac®. Both gels contain the same active ingredients. Researchers want to see if the new gel works just as well and is safe for treating acne.